Nova Wellness Group Berhad (KLSE:NOVA)
Malaysia · Delayed Price · Currency is MYR 0.3800
+0.0100 (2.70%)
At close: Aug 28, 2026
KLSE:NOVA Income Statement
Financials in millions MYR. Fiscal year is July - June.
Millions MYR. Fiscal year is Jul - Jun.
Fiscal Year | FY 2026 | FY 2025 | FY 2024 | FY 2023 | FY 2022 |
|---|---|---|---|---|---|
Period Ending | Jun '26 Jun 30, 2026 | Jun '25 Jun 30, 2025 | Jun '24 Jun 30, 2024 | Jun '23 Jun 30, 2023 | Jun '22 Jun 30, 2022 |
| 49.22 | 44.14 | 40.84 | 45.53 | 49.14 | |
Revenue Growth | 11.51% | 8.09% | -10.32% | -7.33% | 21.38% |
Cost of Revenue | 24.11 | 19.85 | 17.4 | 13.48 | 15.19 |
Gross Profit | 25.12 | 24.29 | 23.43 | 32.06 | 33.95 |
Selling, General & Admin | 13.46 | 14.28 | 12.89 | 13.68 | 15.13 |
Research & Development | - | 0.6 | 0.26 | 0.23 | 0.25 |
Other Operating Expenses | 0.29 | - | - | - | - |
Operating Expenses | 13.75 | 14.88 | 13.79 | 14.1 | 15.33 |
Operating Income | 11.37 | 9.41 | 9.64 | 17.95 | 18.62 |
Interest & Investment Income | - | 0.14 | 0.32 | 0.37 | 0.48 |
Currency Exchange Gain (Loss) | - | 0.07 | 0.06 | 0.15 | 0.04 |
Other Non Operating Income (Expenses) | 1.33 | 0.64 | 0.89 | 0.7 | 1.14 |
EBT Excluding Unusual Items | 12.69 | 10.27 | 10.9 | 19.17 | 20.28 |
Gain (Loss) on Sale of Assets | - | - | - | 0.59 | - |
Pretax Income | 12.69 | 10.27 | 10.9 | 19.76 | 20.28 |
Income Tax Expense | 3.34 | 2.54 | 3.03 | 4.77 | 4.18 |
Net Income | 9.35 | 7.73 | 7.87 | 14.99 | 16.11 |
Net Income to Common | 9.35 | 7.73 | 7.87 | 14.99 | 16.11 |
Net Income Growth | 20.95% | -1.72% | -47.52% | -6.91% | 10.64% |
Shares Outstanding (Basic) | 319 | 319 | 319 | 318 | 318 |
Shares Outstanding (Diluted) | 319 | 319 | 319 | 319 | 318 |
Shares Change | - | - | -0.04% | 0.34% | 0.01% |
EPS (Basic) | 0.03 | 0.02 | 0.02 | 0.05 | 0.05 |
EPS (Diluted) | 0.03 | 0.02 | 0.02 | 0.05 | 0.05 |
EPS Growth | 20.77% | -1.72% | -47.48% | -7.27% | 10.67% |
Additional Metrics
Fiscal Year | FY 2026 | FY 2025 | FY 2024 | FY 2023 | FY 2022 |
|---|---|---|---|---|---|
Period Ending | Jun '26 Jun 30, 2026 | Jun '25 Jun 30, 2025 | Jun '24 Jun 30, 2024 | Jun '23 Jun 30, 2023 | Jun '22 Jun 30, 2022 |
Free Cash Flow | 14.7 | 2.27 | 4.76 | -1.76 | 3.15 |
Free Cash Flow Per Share | 0.05 | 0.01 | 0.01 | -0.01 | 0.01 |
Dividend Per Share | 0.016 | 0.016 | 0.013 | 0.021 | 0.021 |
Dividend Growth | 0% | 28.00% | -40.48% | 2.44% | 13.89% |
Gross Margin | 51.03% | 55.04% | 57.38% | 70.40% | 69.09% |
Operating Margin | 23.09% | 21.33% | 23.60% | 39.43% | 37.90% |
Profit Margin | 19.00% | 17.52% | 19.27% | 32.92% | 32.78% |
Free Cash Flow Margin | 29.86% | 5.13% | 11.65% | -3.87% | 6.42% |
EBITDA | 14.5 | 11.05 | 11.16 | 19.24 | 19.79 |
EBITDA Margin | 29.46% | 25.02% | 27.32% | 42.25% | 40.27% |
D&A For EBITDA | 3.14 | 1.63 | 1.52 | 1.28 | 1.17 |
EBIT | 11.37 | 9.41 | 9.64 | 17.95 | 18.62 |
EBIT Margin | 23.09% | 21.33% | 23.60% | 39.43% | 37.90% |
Effective Tax Rate | 26.31% | 24.69% | 27.83% | 24.13% | 20.60% |